Dupilumab Effect on Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma with an Allergic Phenotype

被引：0
|
作者：
Castro, M. [1 ]
Corren, J. [2 ,3 ]
Casale, T. B.
Quirce, S. [4 ]
Rice, M. S. [5 ]
Deniz, Y. [6 ]
Rowe, P. [5 ]
Amin, N. [6 ]
Teper, A. [5 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO 14263 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA
[3] Univ S Florida, Tampa, FL 33620 USA
[4] Hosp La Paz Inst Hlth Res Idipaz, Madrid, Spain
[5] Sanofi, Paris, France
[6] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
来源：
PNEUMOLOGIE | 2020年 / 74卷
关键词：
D O I：
10.1055/s-0039-3403258
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P100
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [31] Effect of dupilumab on sputum eosinophils in patients with moderate-to-severe asthma
    Svenningsen, Sarah
    Kjarsgaard, Melanie
    Zhang, Kayla
    Serajeddini, Hana
    Garrido, Carmen Venegas
    Bhalla, Anurag
    Radford, Katherine
    Huang, Chynna
    Ho, Terence
    Ragunayakam, Nandhitha
    Thakar, Ashutosh
    Radadia, Nisarg
    Mukherjee, Manali
    Nair, Parameswaran
    ALLERGY, 2024, 79 (02) : 509 - 513
  • [32] Dupilumab in moderate-to-severe asthma
    Mellis, Craig
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2022, 58 (01) : 209 - 209
  • [33] Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma
    Papi, Alberto
    Corren, Jonathan
    Castro, Mario
    Domingo, Christian
    Rogers, Linda
    Chapman, Kenneth R.
    Jackson, Daniel J.
    Daizadeh, Nadia
    Pandit-Abid, Nami
    Gall, Rebecca
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    Ortiz, Benjamin
    ALLERGY, 2023, 78 (01) : 233 - 243
  • [34] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Asthma by Immunoglobin E Levels at Baseline
    Carr, Warner
    Jackson, David J.
    Corren, Jonathan
    Bergmann, Karl-Christian
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Amin, Nikhil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [35] Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
    Hanania, N. A.
    Bateman, E. D.
    Castro, M.
    Pavord, I. D.
    Papi, A.
    FitzGerald, J. M.
    Maspero, J. F.
    Katelaris, C.
    Singh, D.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [36] Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma
    Peters, Anju T.
    Sagara, Hironori
    Corren, Jonathan
    Domingo, Christian
    Altincatal, Arman
    Soler, Xavier
    Pandit-Abid, Nami
    Crikelair, Nora
    Rowe, Paul J.
    Jacob-Nara, Juby A.
    Deniz, Yamo
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (04) : 477 - 484.e4
  • [37] Dupilumab Efficacy in LIBERTY ASTHMA QUEST Patients With Uncontrolled, Moderate-to-Severe Asthma By Allergen Sensitization Status
    Corren, Jonathan
    Jackson, David
    Casale, Thomas
    Borish, Larry
    Rabe, Klaus
    Busse, William
    Maspero, Jorge
    Jackson, Daniel
    Daizadeh, Nadia
    Ortiz, Benjamin
    Jacob-Nara, Juby
    Khodzhayev, Angela
    Rowe, Paul
    Djandji, Michel
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB15 - AB15
  • [38] Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-to-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study
    Busse, William W.
    Maspero, Jorge F.
    Hanania, Nicola A.
    Fitz-Gerald, J. Mark
    Ford, Linda B.
    Rice, Megan
    Lu, Yufang
    Rowe, Paul
    Staudinger, Heribert
    Amin, Nikhil
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB97 - AB97
  • [39] Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma
    Busse, William W.
    Humbert, Marc
    Haselkorn, Tmirah
    Ortiz, Benjamin
    Trzaskoma, Benjamin L.
    Stephenson, Patricia
    Conde, Lorena Garcia
    Kianifard, Farid
    Holgate, Stephen T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 124 (02) : 190 - 196
  • [40] Dupilumab Reduces Severe Exacerbations and Improves Lung Function Regardless of Baseline Bronchodilator Reversibility in Patients with Uncontrolled Moderate-to-Severe Asthma Enrolled in the LIBERTY ASTHMA QUEST Study
    Pavord, I.
    Castro, M.
    Rabe, K. F.
    Hanania, N. A.
    Papi, A.
    FitzGerald, J. M.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345